The significant reduction in phosphatidylcholine (PC) levels in newly diagnosed type 2 diabetes (T2D) patients and high-risk individuals indicates disrupted lipid metabolism, which may affect membrane integrity and insulin signaling [20]. The gene discussed is INS; the disease is type 2 diabetes mellitus.